Comments
Uncertainty looms over Keryx, Aeterna cancer drug
03.04.2012. | (Reuters) - Keryx Biopharmaceuticals Inc and Aeterna Zentaris said their experimental colorectal cancer drug did not meet the main goal of a late-stage trial, raising doubts on the drug's future as a treatment for a type of blood cancer....
